The biotech industry is in an exciting period of growth and innovation, the number of new products being registered continues to increase year on year, with a significant proportion of these being novel, first in class medicines. An increasing number of companies are choosing to come to market alone, without a larger established partner, and the time to registration is decreasing as many of these novel therapies are granted accelerated approval. As a result, many companies are facing the challenge of commercialization for the first time and sometimes sooner than they may have anticipated.
Complete the information below to download your free copy of the White Paper
For further information about our range of servicesContact Us
White paper by Jeffrey M. Bockman, PhD. Biotech and Breakthroughs in Immuno-Oncology
Join us at Cancer Progress, Virtual May 4-6 2021 ❝ Inspiring Cancer Progress through engaged stakeholder dialogue ❞
In this simple infographic we describe 15 drug innovations throughout recent history, from the first successful vaccine developed in the late 18th century to today’s personalised gene therapy treatments.
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us